全文获取类型
收费全文 | 13466篇 |
免费 | 900篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 121篇 |
儿科学 | 420篇 |
妇产科学 | 484篇 |
基础医学 | 1799篇 |
口腔科学 | 131篇 |
临床医学 | 2575篇 |
内科学 | 2306篇 |
皮肤病学 | 240篇 |
神经病学 | 1176篇 |
特种医学 | 252篇 |
外科学 | 1120篇 |
综合类 | 109篇 |
一般理论 | 17篇 |
预防医学 | 1737篇 |
眼科学 | 119篇 |
药学 | 825篇 |
中国医学 | 12篇 |
肿瘤学 | 952篇 |
出版年
2023年 | 50篇 |
2022年 | 89篇 |
2021年 | 208篇 |
2020年 | 134篇 |
2019年 | 253篇 |
2018年 | 295篇 |
2017年 | 181篇 |
2016年 | 236篇 |
2015年 | 266篇 |
2014年 | 395篇 |
2013年 | 658篇 |
2012年 | 971篇 |
2011年 | 1042篇 |
2010年 | 539篇 |
2009年 | 488篇 |
2008年 | 1015篇 |
2007年 | 1039篇 |
2006年 | 1027篇 |
2005年 | 988篇 |
2004年 | 933篇 |
2003年 | 869篇 |
2002年 | 892篇 |
2001年 | 93篇 |
2000年 | 60篇 |
1999年 | 123篇 |
1998年 | 204篇 |
1997年 | 131篇 |
1996年 | 123篇 |
1995年 | 103篇 |
1994年 | 94篇 |
1993年 | 90篇 |
1992年 | 60篇 |
1991年 | 51篇 |
1990年 | 59篇 |
1989年 | 46篇 |
1988年 | 47篇 |
1987年 | 43篇 |
1986年 | 37篇 |
1985年 | 34篇 |
1984年 | 41篇 |
1983年 | 48篇 |
1982年 | 60篇 |
1981年 | 51篇 |
1980年 | 48篇 |
1979年 | 20篇 |
1978年 | 29篇 |
1977年 | 20篇 |
1976年 | 20篇 |
1975年 | 16篇 |
1974年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
The state of pregnancy is an immunological enigma during which the body must prevent rejection of the antigenically foreign fetus while at the same time maintain sufficient maternal host defense mechanisms to combat infection. Although most studies on the immunology of pregnancy focus on immune suppression, several studies have shown an increase in nonspecific host defense, which is postulated to be a compensatory mechanism for decreased specific immunity during pregnancy. Studies in this laboratory have shown that monocyte surface FcγRI (CD64) and FcγRII (CD32) expression progressively increase throughout pregnancy, while surface MHC class II expression remains unchanged. Functional studies revealed that the number of phagocytic monocytes which could be isolated from pregnant women was increased. These cells exhibited an increased capacity to ingest IgG-opsonized human erythrocytes. This study shows for the first time that monocyte surface FcγR expression and FcγR-mediated functions are increased during pregnancy. These results support the hypothesis that nonspecific immunity as represented by FcγR expression and function is increased during pregnancy. 相似文献
12.
13.
14.
15.
16.
Sheetal Chopra Anna S Lev-Toaff Fatih Ors Diane Bergin 《Journal of ultrasound in medicine》2006,25(5):617-27; quiz 629
OBJECTIVE: The purpose of this presentation is to show the imaging findings of the common and uncommon variants of adenomyosis as seen on sonography and magnetic resonance imaging (MRI). METHODS: A 3-year database search was performed to identify women who had pelvic sonography and pelvic MRI within a 6-month interval. Images of these cases were retrospectively reviewed. RESULTS: Eighty women were identified. Adenomyosis was diagnosed on MRI, which was used as the reference standard, in 45 of these women. The correct diagnosis was made on sonography in 73% of the cases. CONCLUSIONS: Awareness of the spectrum of imaging features of adenomyosis is important to use sonography effectively for diagnosing this entity and to help avoid misdiagnosis. 相似文献
17.
Impact of smoking on cancer stage at diagnosis. 总被引:2,自引:0,他引:2
Nathan L Kobrinsky Marilyn G Klug Peggy Jo Hokanson Diane E Sjolander Larry Burd 《Journal of clinical oncology》2003,21(5):907-913
BACKGROUND: Studies evaluating the relationship between smoking and cancer spread are limited. METHODS: We studied the relationship between cancer stage at diagnosis (local, regional, or metastatic) and smoking history (current, previous, or nonsmoker). For lung cancer, patterns of spread were also studied. RESULTS: In a tumor registry for eastern North Dakota, northwestern Minnesota, and northern South Dakota, 11,716 cases were identified from 1986 to 2001. Current smokers (relative risk [RR], 2.11; 95% confidence interval, 1.93 to 2.32; P <.001) and previous smokers (RR, 1.56; 95% confidence interval, 1.42 to 1.72; P <.001) had an increased risk of metastatic disease at diagnosis. Current smokers (RR, 1.39; 95% confidence interval, 1.29 to 1.51; P <.001), but not previous smokers, also had an increased risk of regional disease. An increase in metastatic disease was most evident for prostate cancer (RR, 1.53; P =.003). An increase in regional disease was most evident for head and neck (RR, 3.53; P <.001), prostate (RR, 1.83; P =.030), and breast cancer (RR, 1.22; P =.005). Compared with previous smokers, current smokers with metastatic lung cancer were more likely to have involvement of the brain (33.6% v 23.0%; P =.004), bone marrow, adrenal gland, and pericardium (24.7% v 15.9%; P =.004). CONCLUSION: Previous or current smoking is a risk factor for increased cancer stage in a wide range of malignancies. Further study is required to determine whether this association is causal. 相似文献
18.
Gregory C Gray Troy McCarthy Mark G Lebeck David P Schnurr Kevin L Russell Adriana E Kajon Marie L Landry Diane S Leland Gregory A Storch Christine C Ginocchio Christine C Robinson Gail J Demmler Michael A Saubolle Sue C Kehl Rangaraj Selvarangan Melissa B Miller James D Chappell Danielle M Zerr Deanna L Kiska Diane C Halstead Ana W Capuano Sharon F Setterquist Margaret L Chorazy Jeffrey D Dawson Dean D Erdman 《Clinical infectious diseases》2007,45(9):1120-1131
BACKGROUND: Recently, epidemiological and clinical data have revealed important changes with regard to clinical adenovirus infection, including alterations in antigenic presentation, geographical distribution, and virulence of the virus. METHODS: In an effort to better understand the epidemiology of clinical adenovirus infection in the United States, we adopted a new molecular adenovirus typing technique to study clinical adenovirus isolates collected from 22 medical facilities over a 25-month period during 2004-2006. A hexon gene sequence typing method was used to characterize 2237 clinical adenovirus-positive specimens, comparing their sequences with those of the 51 currently recognized prototype human adenovirus strains. In a blinded comparison, this method performed well and was much faster than the classic serologic typing method. RESULTS: Among civilians, the most prevalent adenovirus types were types 3 (prevalence, 34.6%), 2 (24.3%), 1 (17.7%), and 5 (5.3%). Among military trainees, the most prevalent types were types 4 (prevalence, 92.8%), 3 (2.6%), and 21 (2.4%). CONCLUSIONS: For both populations, we observed a statistically significant increasing trend of adenovirus type 21 detection over time. Among adenovirus isolates recovered from specimens from civilians, 50% were associated with hospitalization, 19.6% with a chronic disease condition, 11% with a bone marrow or solid organ transplantation, 7.4% with intensive care unit stay, and 4.2% with a cancer diagnosis. Multivariable risk factor modeling for adenovirus disease severity found that age <7 years (odds ratio [OR], 3.2; 95% confidence interval [CI], 1.4-7.4), chronic disease (OR, 3.6; 95% CI, 2.6-5.1), recent transplantation (OR, 2.7; 95% CI, 1.3-5.2), and adenovirus type 5 (OR, 2.7; 95% CI, 1.5-4.7) or type 21 infection (OR, 7.6; 95% CI, 2.6-22.3) increased the risk of severe disease. 相似文献
19.
20.
Jin S. Lee Herman I. Libshitz William K. Murphy Diane Jeffries Waun K. Hong 《Investigational new drugs》1990,8(3):299-304
Summary Thirty-one patients with stage IIIB or IV non-small cell lung cancer (NSCLC) were treated with intravenous 10-EdAM on a weekly basis. The starting dose was 80 mg/m2, with subsequent doses adjusted depending on evidence of toxicity. There were 20 men and 11 women with a median age of 58 years (range, 33–75). Response was evaluated in 30 patients, 5 with evaluable but not measurable tumors and 25 with measurable indicator lesions. There were no complete remissions; 3 patients achieved partial remission. Nine patients had a minor response, 6 showed no change, and 12 had progressive disease. Median survival for all 31 patients was 43 weeks (range, 12–65+). During the first 3-week period, the 10-EdAM dose was reduced or withheld in 19 patients (because of stomatitis in 12, SGPT elevation in 3, skin rash in 2, and granulocytopenia in 2), escalated in 11 patients, and unchanged in 1 patient. A mean of 34–88 mg/m2of 10-EdAM (median, 50) was given per week during the first 5-week period. Myelotoxicity was infrequent and there was no significant nephrotoxicity. Considering the modest side effects of this treatment and the conservative dose-modification schedule which mandated substantial dose reductions, we conclude that 10-EdAM is a promising antitumor agent for NSCLC. 相似文献